hotspot -WSS

hotspot

author：focus 2025-09-28 23:48:32 - browse：8367

What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Cancer drug shortages should be causing more outrage
Next article： New report analyzes digital physical therapy solutions' effectiveness

focus

WSS

Pfizer, Moderna say biotech, pharma drug development is a sprint

STAT Virtual Event: ASCO Recap, Live!

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Mirador, a new biotech startup, launches with $400 million

Erich Jarvis studies song birds to learn about human stuttering

What Kate Middleton's cancer revelation might teach the world

Wikipedia

hotspot

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Pharma companies must ensure equitable access to obesity drugs

Medicare details structure of new drug price negotiation program

Teladoc has a new CEO, but challenges remain the same

Moonlake's readout produced a cash windfall. Risks remain

Mirador, a new biotech startup, launches with $400 million

How one medical school became remarkably diverse

Mirador, a new biotech startup, launches with $400 million

Anesthesiologist group: stop taking Ozempic before surgery

Chinese researcher claims birth of first gene

hotspot

Deposition: Sackler embraced plan to conceal OxyContin’s strength

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Curing rare childhood diseases will falter unless Congress steps up

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

California wildfire smoke linked to 52,000 early deaths, study says

hotspot

knowledge

focus

Wikipedia